NAVIGATE Reproductive Center of Excellence (Network for Assessment, Validation, Innovation, Guidance, Access, Treatment and Evaluation)
- Response deadline
- Aug 5, 2026 Closed
- Date posted
- Jun 23, 2026
- Source
- Open notice
Description
The Office of the Assistant Secretary for Health (OASH) Office on Women's Health (OWH) announces the anticipated availability of funds for Fiscal Year (FY) 2026 grants under the authority of section 229 of the Public Health Service (PHS) Act (42 U.S.C. § 237a), section 1703(a) of the PHS Act (42 U.S.C. § 300u-2(a)), and all of the authorities under Title XVII of the Public Health Service Act, as amended, pertaining to the mission of the Office on Women's Health." 73 Fed. Reg. 62995 (Oct 2008).This notice solicits applications from organizations with demonstrated experience in the prevention, diagnosis, and treatment of reproductive health conditions, which may include polyendocrine metabolic ovarian syndrome (PMOS, formerly known as polycystic ovary syndrome or PCOS), endometriosis, uterine fibroids, infertility, pelvic inflammatory disease (PID), reproductive-age endocrine disorders, or recurrent miscarriage. Through this cooperative agreement, selected organizations will be recognized and elevated as a Center of Excellence, building on their existing expertise to strengthen the translation of evidence into practice, enhance and standardize root-cause care pathways, expand workforce training, and improve health outcomes for women. OWH encourages applicants to review all program requirements, eligibility information, application format and submission information, evaluation criteria, and other information in this funding announcement to ensure that their application complies with all requirements and instructions.
Classifications
- NAICS93.088
Documents (1)
- DownloadWH-AST-26-003 NAVIGATE.pdfapplication/pdf652 KB
Contacts
Similar contracts
- Medical Forensic Access InitiativeDue Aug 5, 2026
- Protecting and Rehabilitating Sexually Exploited Women and Girls Through Long-Term Safe HomesDue Jul 20, 2026
- Protecting Women and Girls through Founding and Replication of Existing Long-Term Safe HomesDue Jul 20, 2026
- Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)Due Feb 8, 2028
- NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food SpecimensDue Apr 1, 2027
- Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not AllowedDue Apr 1, 2027